12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Tuesday's intraday session. Ensysce Biosciences, ENDRA Life Sciences, and Genprex saw substantial gains, while IN8bio, GRI Bio, and Voyager Therapeutics faced notable declines.
October 22, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ensysce Biosciences' stock surged by 120% to $0.45, significantly increasing its market cap to $6.2 million.
The 120% increase in ENSC's stock price indicates strong positive sentiment or news, likely leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Genprex shares increased by 90.15% to $2.87, raising its market cap to $7.4 million.
The 90% increase in GNPX's stock price indicates strong investor interest, likely leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
ENDRA Life Sciences' stock rose 102.48% to $0.45, with a market cap of $8.1 million.
The 102% rise in NDRA's stock suggests a strong positive catalyst, likely leading to continued short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
GRI Bio's stock decreased by 28.74% to $0.94, with a market cap of $2.7 million.
The 28% drop in GRI's stock price indicates negative investor sentiment, likely leading to continued short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
IN8bio's stock fell 30.5% to $0.33, reducing its market cap to $23.9 million.
The 30% decline in INAB's stock suggests negative sentiment or news, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Voyager Therapeutics' stock decreased by 19.52% to $6.17, reducing its market cap to $336.1 million.
The 19% decline in VYGR's stock suggests negative news or sentiment, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100